GNRH1 and ovarian hyperstimulation syndrome: However, while cabergoline has been effective in reducing early OHSS in gonadotropin release hormone (GnRH) agonists in vitro fertilization (IVF) cycles, it has not been able to prevent severe cases of OHSS [10].